RUSSO, FRANCESCO PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 132
EU - Europa 82
AS - Asia 20
AF - Africa 12
Totale 246
Nazione #
US - Stati Uniti d'America 132
IT - Italia 57
NL - Olanda 14
CI - Costa d'Avorio 12
CN - Cina 11
IN - India 8
UA - Ucraina 5
DE - Germania 3
IE - Irlanda 2
FI - Finlandia 1
MY - Malesia 1
Totale 246
Città #
Chandler 25
Ashburn 15
Amsterdam 14
Naples 14
Napoli 7
Pune 7
Boston 4
Des Moines 4
Jacksonville 4
Millbury 4
Pomigliano D'arco 4
Princeton 4
Acquaviva Delle Fonti 2
Dublin 2
Gualtieri 2
Hebei 2
Lawrence 2
Los Angeles 2
Nanjing 2
Nocera Inferiore 2
Sorrento 2
Tianjin 2
Vittorio Veneto 2
Agropoli 1
Bari 1
Beijing 1
Caivano 1
Cologne 1
Jiaxing 1
Kronberg 1
Marano 1
Nanchang 1
Orange 1
Palermo 1
Petaling Jaya 1
San Giovanni Lupatoto 1
San Giuseppe Vesuviano 1
Sedriano 1
Shenyang 1
Washington 1
Wilmington 1
Totale 146
Nome #
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 55
Treatment of Hepatitis C virus infection in Italy: A consensus report from an expert panel 36
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network 33
Quattro nuove stazioni della linea 1 della Metropolitana di Napoli: problematiche geotecniche, procedure di analisi e scelte progettuali 30
Advanced liver disease outcomes after hepatitis C eradication by human immunodeficiency virus infection in PITER cohort 29
Modeling cost-effectiveness and health gains of a “universal” versus “prioritized” hepatitis C virus treatment policy in a real-life cohort 25
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 15
Overview of prognostic systems for hepatocellular carcinoma and ITA.LI.CA external validation of MESH and CNLC classifications 15
Surveillance for hepatocellular carcinoma with a 3-months interval in “extremely high-risk” patients does not further improve survival 13
A prospective study of direct-acting antiviral effectiveness and relapse risk in HCV cryoglobulinemic vasculitis by the Italian PITER cohort 5
Profiling the risk of hepatocellular carcinoma after long-term HCV eradication in patients with liver cirrhosis in the PITER cohort 5
null 4
Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination 2
Totale 267
Categoria #
all - tutte 1.287
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.287


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20197 0 0 0 0 0 0 0 0 0 0 2 5
2019/202020 11 0 2 1 2 0 0 0 1 1 1 1
2020/202118 0 1 0 3 5 0 1 0 7 0 1 0
2021/202231 0 0 0 0 0 0 0 0 0 6 12 13
2022/202390 6 2 0 3 13 8 2 12 19 19 6 0
2023/202482 1 16 19 7 4 13 0 14 2 6 0 0
Totale 267